Wrecklimid: How treating generic drugs as something special can wreck affordability
Ben LinkMedicare, PBM, Part D, Mark Cuban, Express Scripts, CVS, Optum, Medicaid, AWP, NADAC, Revlimid, specialty drugs, TriCare, Zytiga, Abieraterone, atorvastatin, lenalidomide, WAC
This drug pricing distortion was supposed to go extinct. It’s never been more alive.
Ben LinkMedicare, PBM, Part D, Mark Cuban, Express Scripts, CVS, Optum, Quallent Pharmaceuticals, Imatinib, Medicaid, AWP, NADAC, WAC, Albendazole, FTC, Archis Pharma
Are generic drug prices going up or down? Depends on which benchmark you ask
How PBMs can use private-labelled drug products as a great escape from anti-steering policies
Ben LinkMedicare, PBM, Part D, Mark Cuban, Express Scripts, CVS, Optum, Kaiser, 340B, Quallent Pharmaceuticals, Cordavis, Nuvaila, PBM steering, Imatinib, Capecitabine, Aripiprazole, Medicaid, Lisinopril
Medicare’s addiction to disconnected drug prices
Ben LinkGeneric, Medicare, PBM, Part D, AWP, dispensing fee, Transparency in Coverage, Suboxone, Buprenorphine-naloxone, opioid use disorder, addiction treatment, NADAC, Medicaid
Is 2024 the start of a brave new world in drug pricing?
Ben LinkWAC, AWP, PBM, Brand drugs, Generic drugs, NADAC, CVS, Express Scripts, Medicaid, Mark Cuban, Insulin, Flovent, Price increases, List prices, Rebates, American Rescue Plan, Inflation Reduction Act, AMP
How PBMs distort and undermine specialty drug pricing guarantees
Ben LinkSpecialty, WAC, AWP, specialty drugs, PBM, Brand drugs, Generic drugs, Effective rate, NADAC, Linda Cahn, CVS, Express Scripts, Optum, Emgality, Retevmo, Imatinib, Gleevec, Hyalgan, Medicaid, Medicare, Mark Cuban, Ohio
The Rise of the Drug Mix Empire
Two new dashboards released to assist with drug shortage research
Ben LinkCOVID-19, China, India, FDA, Drug shortages, drug prices, NADAC, Omeprazole, Medicaid, Prilosec, Lisinopril, Epclusa, sofosbuvir, naproxen, hydrocodone, ranitidine, hydroxychloroquine
